Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Hair Loss Clinical Trials

A listing of Hair Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (29) clinical trials

Intralesional Steroids in the Treatment of Alopecia Areata

Alopecia areata (AA) is a major medical problem and is the most prevalent autoimmune disease in the US. AA represents the second most common form of hair loss and causes significant disfigurement and psychological distress to affected individuals. AA affects more individuals than most other autoimmune diseases combined, including lupus ...

Phase

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

This study was designed to better assess the efficacy of PRP in hair loss, we therefore propose to study interval intralesional PRP injections for patients with androgenetic alopecia (AGA). Androgenetic alopecia is the most common form of hair loss world-wide. Although there are currently numerous treatment options for this indication ...

Phase N/A

Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

This clinical trial attempts to investigate the efficacy of LEO 124249 ointment in the treatment of alopecia areata on the eyebrows.

Phase

Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain

Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can contribute to the distress and social isolation of patients with advanced cancer. In this study a topical gel will be applied directly to the scalp during each dose of radiotherapy. The goal is to ...

Phase

Alopecia Areata Registry and Immunogenetic Mechanisms

The purpose of this registry is to collect patient epidemiology data as well as to provide samples that can be used for understanding the pathogenesis of AA, especially related to its genetic basis as a complex trait. There are three ways one can assess which genes are important: association studies ...

Phase N/A

Efficacy Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

The aim of this trial is to compare the degree of efficacy, safety and tolerability of CG 428 cutaneous solution versus placebo on prevention of chemotherapy induced alopecia (CIA) in female patients with metastatic cancer treated with selected regimens inducing alopecia.

Phase

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

This is a Phase 2a, randomized, double blind, parallel group, multicenter study with an extension period. The study will have a maximum duration of approximately 85 weeks. This includes an up to 5 weeks screening period, a 24 week treatment period, a 4 week drug holiday, an up to 12 ...

Phase

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

The aesthetic surgical & cosmetic discipline of hair restoration is rooted in numerous landmark studies and progressive medical science in the medical literature. With the advent of advanced theories and science using cellular and platelet-derived growth factors within the scope of regenerative medicine, have been well established in a number ...

Phase N/A

Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

This is a double-blind, randomized, placebo-controlled multi-center study consisting of 2 cohorts to assess the safety and efficacy of CTP-543. Each Cohort will be initiated sequentially in ascending dose order. Subjects will be randomized to either an active dose of CTP-543 or placebo for a 24-week treatment period.

Phase

Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females

This study verifies whether the tested product has any efficacy in the treatment of Alopecia Areata. The evaluated product (Hair Loss prevention Lotion) is called: MEXIS, MPAF, M6S PATENT. 20 volunteers both men and women suffering from hair loss both in parties and over the entire scalp with age between ...

Phase N/A